Climate Action category

Monash Institute of Pharmaceutical Sciences (MIPS) is addressing the dual challenge that medicines both respond to and contribute to climate change. Through an institute-wide climate health initiative, MIPS is embedding sustainability across research, education and operations, transforming an energy-intensive research environment into a model for low-carbon innovation.

The initiative has implemented coordinated operational and behavioural change at scale, with 80% of laboratories engaged in My Green Lab certification; the highest number of participating My Green Lab laboratories and Green-level certifications nationwide.

By embedding sustainability capability through staff training, student learning and industry partnerships focused on Scope 3 emissions, the initiative is delivering measurable outcomes. It establishes a scalable, sector-leading model for sustainable pharmaceutical science.

Monash Institute of Pharmaceutical Sciences
logo

Top 3 learnings

  • Data transparency drives engagement: Sharing lab-specific energy metrics motivates sustainable behaviour shifts.
  • Industry partnerships accelerate impact: Supply chain collaboration can unlock important Scope 3 emissions reductions.
  • Majority adoption normalises sustainability: When most laboratories integrate it, sustainable practices and procurement become standard.

Supported by

logo
logo
Climate Action category

Monash Institute of Pharmaceutical Sciences (MIPS) is addressing the dual challenge that medicines both respond to and contribute to climate change. Through an institute-wide climate health initiative, MIPS is embedding sustainability across research, education and operations, transforming an energy-intensive research environment into a model for low-carbon innovation.

The initiative has implemented coordinated operational and behavioural change at scale, with 80% of laboratories engaged in My Green Lab certification; the highest number of participating My Green Lab laboratories and Green-level certifications nationwide.

By embedding sustainability capability through staff training, student learning and industry partnerships focused on Scope 3 emissions, the initiative is delivering measurable outcomes. It establishes a scalable, sector-leading model for sustainable pharmaceutical science.

Top 3 learnings

  • Data transparency drives engagement: Sharing lab-specific energy metrics motivates sustainable behaviour shifts.
  • Industry partnerships accelerate impact: Supply chain collaboration can unlock important Scope 3 emissions reductions.
  • Majority adoption normalises sustainability: When most laboratories integrate it, sustainable practices and procurement become standard.